Angiotensin‐Converting Enzyme Inhibitor Use in the Year 2005

Author:

Sica Domenic A.1

Affiliation:

1. From the Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Virginia Commonwealth University Health System, Richmond, VA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference16 articles.

1. Cardiovascular Pharmacotherapeutics 2003 McGraw‐Hill DA Sica TWB Gehr WH Frishman W Frishman S Sonnenblick DA Sica The renin‐angiotensin axis: angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers 131 156

2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report

3. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators;Effects of an angiotensin‐converting‐enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high‐risk patients;N Engl J Med,2000

4. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

5. EUROPA: Has Anything New Been Learned With Angiotensin‐Converting Enzyme Inhibitors?

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3